Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014285110> ?p ?o ?g. }
- W3014285110 endingPage "2973" @default.
- W3014285110 startingPage "2965" @default.
- W3014285110 abstract "Abstract Aims Intravascular ultrasound (IVUS) imaging can visualize vulnerable plaque features including attenuation (AP) and echolucency (ELP). While IVUS-derived vulnerable plaque features associate with microvascular obstruction during percutaneous coronary intervention, the relationship between these plaque features and clinical outcomes has not been established. This analysis aimed to evaluate the association of AP/ELP with cardiovascular events. Methods and results Serial IVUS imaging was reviewed in 1497 patients, followed for 18–24 months, with coronary artery disease from two clinical trials. Attenuated plaque and ELP were identified to measure each characteristics (AP arc, ELP area, and lengths), which permitted calculation of an AP index (API) and ELP volume. Attenuated plaque/ELP progression was defined as patients with any increase of API or ELP volume on serial imaging. The major cardiovascular events (MACEs) were defined as death, myocardial infarction, stroke, and coronary revascularization. AP or ELP was identified in 282 patients (18.8%) at baseline and 160 (10.7%) patients demonstrated an increase in AP or ELP at follow-up. The incidence of MACE was higher in patients with baseline AP/ELP than those without (8.2% vs. 3.9%, P = 0.002). Patients with AP/ELP progression were more likely to be acute coronary syndrome (41.9 vs. 33.2%, P = 0.03) and have greater baseline percent atheroma volume (40.0% vs. 35.8%, P < 0.001) than those without. On multivariable analysis, AP/ELP progression was more strongly associated with MACE [baseline AP/ELP: hazard ratio (HR) 1.76, 95% confidence interval (CI) 1.05–2.97, AP/ELP progression: HR 2.19, 95% CI 1.24–3.86]. Conclusion Attenuation/ELP progression was associated with a higher prevalence of cardiovascular events, supporting a potential role for the identification of high-risk vulnerable plaques in patients with coronary artery disease." @default.
- W3014285110 created "2020-04-10" @default.
- W3014285110 creator A5000362150 @default.
- W3014285110 creator A5001116847 @default.
- W3014285110 creator A5005228563 @default.
- W3014285110 creator A5006777529 @default.
- W3014285110 creator A5030189527 @default.
- W3014285110 creator A5040589473 @default.
- W3014285110 creator A5055849986 @default.
- W3014285110 creator A5059387702 @default.
- W3014285110 creator A5081575819 @default.
- W3014285110 creator A5087247030 @default.
- W3014285110 creator A5087346522 @default.
- W3014285110 date "2020-04-03" @default.
- W3014285110 modified "2023-10-11" @default.
- W3014285110 title "Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events" @default.
- W3014285110 cites W135846028 @default.
- W3014285110 cites W1993047634 @default.
- W3014285110 cites W2020022341 @default.
- W3014285110 cites W2034033536 @default.
- W3014285110 cites W2054455620 @default.
- W3014285110 cites W2056396092 @default.
- W3014285110 cites W2087255170 @default.
- W3014285110 cites W2093631484 @default.
- W3014285110 cites W2110551379 @default.
- W3014285110 cites W2126374403 @default.
- W3014285110 cites W2127933204 @default.
- W3014285110 cites W2131110587 @default.
- W3014285110 cites W2133841044 @default.
- W3014285110 cites W2143360708 @default.
- W3014285110 cites W2144107403 @default.
- W3014285110 cites W2166965931 @default.
- W3014285110 cites W22029071 @default.
- W3014285110 cites W2412291070 @default.
- W3014285110 cites W2561944122 @default.
- W3014285110 cites W65842343 @default.
- W3014285110 doi "https://doi.org/10.1093/eurheartj/ehaa173" @default.
- W3014285110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32243512" @default.
- W3014285110 hasPublicationYear "2020" @default.
- W3014285110 type Work @default.
- W3014285110 sameAs 3014285110 @default.
- W3014285110 citedByCount "17" @default.
- W3014285110 countsByYear W30142851102020 @default.
- W3014285110 countsByYear W30142851102021 @default.
- W3014285110 countsByYear W30142851102022 @default.
- W3014285110 countsByYear W30142851102023 @default.
- W3014285110 crossrefType "journal-article" @default.
- W3014285110 hasAuthorship W3014285110A5000362150 @default.
- W3014285110 hasAuthorship W3014285110A5001116847 @default.
- W3014285110 hasAuthorship W3014285110A5005228563 @default.
- W3014285110 hasAuthorship W3014285110A5006777529 @default.
- W3014285110 hasAuthorship W3014285110A5030189527 @default.
- W3014285110 hasAuthorship W3014285110A5040589473 @default.
- W3014285110 hasAuthorship W3014285110A5055849986 @default.
- W3014285110 hasAuthorship W3014285110A5059387702 @default.
- W3014285110 hasAuthorship W3014285110A5081575819 @default.
- W3014285110 hasAuthorship W3014285110A5087247030 @default.
- W3014285110 hasAuthorship W3014285110A5087346522 @default.
- W3014285110 hasBestOaLocation W30142851101 @default.
- W3014285110 hasConcept C126322002 @default.
- W3014285110 hasConcept C164705383 @default.
- W3014285110 hasConcept C207103383 @default.
- W3014285110 hasConcept C2776931568 @default.
- W3014285110 hasConcept C2777698277 @default.
- W3014285110 hasConcept C2778213512 @default.
- W3014285110 hasConcept C2778710248 @default.
- W3014285110 hasConcept C2779179121 @default.
- W3014285110 hasConcept C2779318932 @default.
- W3014285110 hasConcept C2779464278 @default.
- W3014285110 hasConcept C2780400711 @default.
- W3014285110 hasConcept C2780739214 @default.
- W3014285110 hasConcept C44249647 @default.
- W3014285110 hasConcept C500558357 @default.
- W3014285110 hasConcept C71924100 @default.
- W3014285110 hasConceptScore W3014285110C126322002 @default.
- W3014285110 hasConceptScore W3014285110C164705383 @default.
- W3014285110 hasConceptScore W3014285110C207103383 @default.
- W3014285110 hasConceptScore W3014285110C2776931568 @default.
- W3014285110 hasConceptScore W3014285110C2777698277 @default.
- W3014285110 hasConceptScore W3014285110C2778213512 @default.
- W3014285110 hasConceptScore W3014285110C2778710248 @default.
- W3014285110 hasConceptScore W3014285110C2779179121 @default.
- W3014285110 hasConceptScore W3014285110C2779318932 @default.
- W3014285110 hasConceptScore W3014285110C2779464278 @default.
- W3014285110 hasConceptScore W3014285110C2780400711 @default.
- W3014285110 hasConceptScore W3014285110C2780739214 @default.
- W3014285110 hasConceptScore W3014285110C44249647 @default.
- W3014285110 hasConceptScore W3014285110C500558357 @default.
- W3014285110 hasConceptScore W3014285110C71924100 @default.
- W3014285110 hasFunder F4320320442 @default.
- W3014285110 hasIssue "31" @default.
- W3014285110 hasLocation W30142851101 @default.
- W3014285110 hasOpenAccess W3014285110 @default.
- W3014285110 hasPrimaryLocation W30142851101 @default.
- W3014285110 hasRelatedWork W1993638248 @default.
- W3014285110 hasRelatedWork W2002781300 @default.
- W3014285110 hasRelatedWork W2089715561 @default.
- W3014285110 hasRelatedWork W2100465349 @default.